Morell, Marķa <br/><br/>
VIP in neurological diseases: more than a neuropeptide.  [electronic resource] 

 -  Endocrine, metabolic & immune disorders drug targets  Dec 2012 
 - 323-32 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review 
<br/><br/><label>ISSN: </label>2212-3873 
<br/><br/><label>Standard No.: </label>10.2174/187153012803832549  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Alzheimer Disease--physiopathology<br/>Animals<br/>Autistic Disorder--physiopathology<br/>Brain--drug effects<br/>Brain Injuries--physiopathology<br/>Developmental Disabilities--drug therapy<br/>Down Syndrome--physiopathology<br/>Encephalitis--drug therapy<br/>Female<br/>Fetal Alcohol Spectrum Disorders--physiopathology<br/>Humans<br/>Mice<br/>Multiple Sclerosis--physiopathology<br/>Nervous System Diseases--drug therapy<br/>Neuroprotective Agents--administration & dosage<br/>Parkinson Disease--physiopathology<br/>Pregnancy<br/>Receptors, Vasoactive Intestinal Peptide--drug effects<br/>Vasoactive Intestinal Peptide--administration & dosage